http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-8403488-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8659631bf38b3a590c0d3edc265492c
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-02
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C29-147
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-568
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D477-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D265-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C29-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D205-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-397
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C29-147
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-695
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D477-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D205-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D477-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C29-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D265-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-568
filingDate 1982-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1983-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-8403488-A1
titleOfInvention A PROCEDURE FOR THE PREPARATION OF B-LACTAMIC ANTIBIOTICS.
abstract PROCEDURE FOR THE PREPARATION OF B-LACTAMIC ANTIBIOTICS, OF A GENERAL FORMULA (I), IN WHICH R1 AND R2 EACH REPRESENT A HYDROGEN ATOM OR AN ORGANIC GROUP UNITED THROUGH A CARBON ATOM TO THE AZABYCYCLO RING; R3 AND R4 EACH REPRESENT AN ORGANIC GROUP UNITED THROUGH A CARBON ATOM TO THE AZABICYCLOHEPTENE RING; AND R6 IS AN ORGANIC GROUP UNITED THROUGH A CARBON ATOM TO THE SULFUR ATOM, AND THE PHARMACEUTICALLY ACCEPTABLE SALTS. CONSISTS OF ELIMINATING THE FORMULA COMPOUND (II) FROM THE HX MOLECULE, WHERE X IS A COMPOUND; AND RA IS A CARBOXY-BLOCKING GROUP OF APPLIOATION AS ANTIBACTERIAL AGENTS.
priorityDate 1981-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421271622
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID402
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419571976
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13293131
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53411096

Total number of triples: 39.